HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Researchers, oncologists embrace the ‘concept of a cure’
-
- Blood type may influence coronary heart disease risk
- Cancer hospital opens in Texas
- CBO estimates repeal of Affordable Care Act would increase spending by $109 billion
- Center opens new oncology program
- CINJ researcher receives award
- IFRT improved event-free survival but did not extend OS in pediatric patients with Hodgkin's lymphoma
- Incidence, survival of acute promyelocytic leukemia increased in United States
- Infants with high birth weight increased mothers’ breast cancer risk
-
- Leukemia researcher honored at ASCO
- Nurse staffing, burnout linked to health care-associated infections
- Prostate cancer survivors experienced treatment-related side effects for up to 10 years
- Transplant program ranks among elite
- UCSD receives QOPI certification
- A 61-year-old woman with moderate hydrocephalus Ramya Varadarajan, MD
- FDA approves ziv-aflibercept for metastatic colorectal cancer
- Like it or not, ‘Big Med’ will be a part of cancer care William Wood, MD
-
- Advanced prostate cancer rate could triple without PSA testing
- Advances in diagnosis, treatment of influenza failed to alter its severity in pediatric cancer patients
- Adverse events more common in new cancer drugs
- Anastrozole and fulvestrant combination extended survival in patients with metastatic breast cancer
- Brentuximab vedotin may be effective for relapsed or refractory systemic ALCL
- Chemotherapy plus radiation failed to extend OS in adults with low-grade glioma
- Dacryocystorhinostomy may improve nasolacrimal duct obstruction after radiation therapy for head, neck cancer
- Fecal immunochemical test was highly sensitive to colorectal cancer
-
- Genetic mutations responsible for childhood brain tumors identified
- Grapefruit juice, ketoconazole increased sirolimus levels in patients with advanced cancer
- Heat-shock factor 1 associated with increased metastasis, mortality
- History of basal cell carcinomas tops future occurrence predictors
- Induction therapy benefited older patients with mantle cell lymphoma
- Lack of initial response to chemoradiotherapy linked to poorer outcome
- Legislation limiting indoor tanning grows worldwide
- Lung cancer death rates increased among white women in US regions
-
- Melanomas among blacks occurred primarily on lower limbs, hips
- Novel rIX-FP product may offer hemophilia B patients prophylaxis with fewer IV injections
- Postmenopausal women benefited from diabetes drug rosiglitazone
- Risk for colorectal cancer decreased among patients with IBD
- Some cases of glioblastoma caused by two fused genes
- Stacked laser pulses cleared nonmelanoma skin cancer in one treatment
- Stereotactic ablative radiotherapy recommended for NSCLC patients at high risk for surgical complications
- Study finds no definitive clinical markers to differentiate class 1, class 2 uveal melanomas
-
- Surgery failed to reduce mortality from PSA detected prostate cancer
- UV sensitivity, HPV seropositivity associated with squamous cell carcinoma
- Vitamin E may reduce risk for liver cancer
- FDA approves treatment for rare type of leukemia
- High hospital volume linked to improved survival in patients with advanced disease